COMP <GO>
ALLO vs EDIT // ENTERPRISE SCALE & MARKET CAP
Allogene Therapeutics Inc. (NASDAQ) VS. Editas Medicine Inc. (NASDAQ) • 15-METRIC TALLY: ALLO 0
— EDIT 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: EDIT
LAST: $1.25 (-3.85%) • MKT CAP: $431.9M
market-cap
$431.9M
LAST: $2.93 (-0.68%) • MKT CAP: $450.0M
market-cap
$450.0M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALLO VS. EDIT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALLO | EDIT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 25.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.3 | 50.8 | -21.51 | EDIT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $431.9M | $450.0M | -$18.1M | EDIT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALLO REV | EDIT REV | ALLO GROSS % | EDIT GROSS % | ALLO FCF | EDIT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $40.5M | — | — | -$149.6M | -$165.8M |
| FY 2024 | $22.0K | $32.3M | — | — | -$201.0M | -$219.1M |
| FY 2023 | $95.0K | $78.1M | — | — | -$237.7M | -$132.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALLO // BETA —
EDIT // BETA —